Pertussis Disease Burden in the Household: How to Protect Young Infants

被引:177
作者
de Greeff, S. C.
Mooi, F. R. [1 ]
Westerhof, A.
Verbakel, J. M. M. [2 ]
Peeters, M. F. [2 ]
Heuvelman, C. J. [1 ]
Notermans, D. W. [1 ]
Elvers, L. H. [1 ]
Schellekens, J. F. P. [3 ]
de Melker, H. E.
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands
[2] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands
[3] Infect Dis Lab, Groningen, Netherlands
关键词
BORDETELLA-PERTUSSIS; BOOSTER VACCINATION; SURVEILLANCE DATA; UNITED-STATES; TRANSMISSION; EPIDEMIOLOGY; POPULATION; INFECTION; IMPACT; IMMUNIZATION;
D O I
10.1086/652281
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We conducted a population-based, nation-wide, prospective study to identify who introduced pertussis into the household of infants aged <= 6 months admitted to the hospital for pertussis in the Netherlands. Methods. During the period 2006-2008, a total of 560 household contacts of 164 hospitalized infants were tested by polymerase chain reaction, culture, and serological examination to establish Bordetella pertussis infection. Clinical symptoms and vaccination history were obtained by a questionnaire submitted during sample collection and 4-6 weeks afterwards. Results. Overall, 299 household contacts (53%) had laboratory-confirmed pertussis; 159 ( 53%) had symptoms compatible with typical pertussis infection, and 42 (14%) had no symptoms. Among children vaccinated with a whole-cell vaccine, 17 (46%) of 37 had typical pertussis 1-3 years after completion of the primary series, compared with 9 (29%) of 31 children who had been completely vaccinated with an acellular vaccine. For 96 households (60%), the most likely source of infection of the infant was established, being a sibling (41%), mother (38%), or father (17%). Conclusions. If immunity to pertussis in parents is maintained or boosted, 35%-55% of infant cases could be prevented. Furthermore, we found that, 1-3 years after vaccination with whole-cell or acellular vaccine, a significant percentage of children are again susceptible for typical pertussis. In the long term, pertussis vaccines and vaccination strategies should be improved to provide longer protection and prevent transmission.
引用
收藏
页码:1339 / 1345
页数:7
相关论文
共 40 条
[11]   Severe and unrecognised: pertussis in UK infants [J].
Crowcroft, NS ;
Booy, R ;
Harrison, T ;
Spicer, L ;
Britto, J ;
Mok, Q ;
Heath, P ;
Murdoch, I ;
Zambon, M ;
George, R ;
Miller, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (09) :802-806
[12]   Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in the Netherlands [J].
de Greeff, Sabine C. ;
Mooi, Frits R. ;
Schellekens, Joop F. P. ;
de Melker, Hester E. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (03) :218-223
[13]   Economic analysis of pertussis illness in the Dutch population: Implications for current and future vaccination strategies [J].
de Greeff, Sabine C. ;
Lugner, Anna K. ;
van den Heuvel, Danielle M. ;
Mooi, Frits R. ;
de Melker, Hester E. .
VACCINE, 2009, 27 (13) :1932-1937
[14]   Reemergence of pertussis in the highly vaccinated population of the Netherlands:: Observations on surveillance data [J].
de Melker, HE ;
Schellekens, JFP ;
Neppelenbroek, SE ;
Mooi, FR ;
Rümke, HC ;
Conyn-van Spaendonck, MAE .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :348-357
[15]   Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis [J].
de Melker, HE ;
Versteegh, FGA ;
Conyn-van Spaendonck, MAE ;
Elvers, LH ;
Berbers, GAM ;
van der Zee, A ;
Schellekens, JFP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :800-806
[16]   HOUSEHOLD CONTACT STUDY OF BORDETELLA-PERTUSSIS INFECTIONS [J].
DEEN, JL ;
MINK, CM ;
CHERRY, JD ;
CHRISTENSON, PD ;
PINEDA, EF ;
LEWIS, K ;
BLUMBERG, DA ;
ROSS, LA .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1211-1219
[17]   National study of infants hospitalized with pertussis in the acellular vaccine era [J].
Elliott, E ;
McIntyre, P ;
Ridley, G ;
Morris, A ;
Massie, J ;
McEniery, J ;
Knight, G .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (03) :246-252
[18]   European Sero-Epidemiology Network:: standardisation of the assay results for pertussis [J].
Giammanco, A ;
Chiarini, A ;
Maple, PAC ;
Andrews, N ;
Pebody, R ;
Gay, N ;
Ölander, RM ;
Fivet-Groyne, R ;
Baron, S ;
Tischer, A ;
Swidsinski, S ;
Schellekens, J ;
Reizenstein, E .
VACCINE, 2003, 22 (01) :112-120
[19]   Influence of vaccination coverage on pertussis transmission in France [J].
Grimprel, E ;
Baron, S ;
Lévy-Bruhl, D ;
Garnier, JM ;
N'jamkepo, E ;
Guiso, N ;
Bégué, P .
LANCET, 1999, 354 (9191) :1699-1700
[20]   Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997:: Report of the Immunization Monitoring Program-Active IMPACT) [J].
Halperin, SA ;
Wang, EEL ;
Law, B ;
Mills, E ;
Morris, R ;
Déry, P ;
Lebel, M ;
MacDonald, N ;
Jadavji, T ;
Vaudry, W ;
Scheifele, D ;
Delage, G ;
Duclos, P .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) :1238-1243